Reviva Pharmaceuticals Holdings, Inc.
RVPH
$0.6762
-$0.0438-6.08%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -55.82% | -42.33% | 11.80% | -44.60% | 6.38% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -36.45% | 262.57% | 201.74% | 52.78% | -7.47% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -53.64% | -38.05% | 26.42% | -38.92% | 4.61% |
|
|||||
Total Current Assets | -53.64% | -38.05% | 26.42% | -38.92% | 4.61% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -47.56% | -34.59% | 41.64% | -32.00% | 4.61% |
|
|||||
Total Accounts Payable | -17.47% | 63.24% | 66.29% | 77.22% | 99.98% |
Total Accrued Expenses | -24.57% | -43.06% | 9.46% | 35.66% | 165.88% |
Short-term Debt | -32.44% | -- | -62.70% | -6.74% | -50.26% |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 27.95% | 24.99% | -- | -- | -- |
Total Other Current Liabilities | 27.95% | 24.99% | -- | -- | -- |
Total Current Liabilities | -20.58% | -14.98% | 34.53% | 51.43% | 120.91% |
|
|||||
Total Current Liabilities | -20.58% | -14.98% | 34.53% | 51.43% | 120.91% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -32.44% | -- | -62.70% | -6.74% | -50.26% |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -92.07% | -88.97% | -91.08% | -85.17% | -36.99% |
Total Liabilities | -22.27% | -18.30% | 26.64% | 37.90% | 108.56% |
|
|||||
Common Stock & APIC | 18.37% | 17.86% | 31.95% | 28.41% | 35.62% |
Retained Earnings | -20.40% | -22.27% | -30.91% | -35.78% | -45.02% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -231.40% | -85.79% | -17.17% | -472.66% | -123.26% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -231.40% | -85.79% | -17.17% | -472.66% | -123.26% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -231.40% | -85.79% | -17.17% | -472.66% | -123.26% |
|